Skip to main content

How can the development of cancer in a damaged liver be avoided?




Press & Communications Section Head
Tel.+34 93 40 37255

The Preguntas Big Van section of La Vanguardia has published an article on a new joint project being done by Raúl Méndez, group leader at the Institute for Research in Biomedicine (IRB Barcelona), together with Mercedes Fernández, researchers at the Instituto de Investigaciones Biomédicas August Pi i Sunyer.

This project seeks to analyse the cells that regulate the activity of genes (CPEB) during liver cancer development.  “We aim to unravel the mechanisms through which CPEBs contribute to tumour onset and growth,” explains Méndez. “If we understand these mechanisms then we might be able to develop pharmacological treatment to prevent or better treat liver cancer”.

This study is part of the “Questions for the Future” programme, run by ”la Caixa”.

Link to: La Vanguardia

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).